Global Metagenomic Sequencing Market
Metagenomic Sequencing Market Size And Forecast
Metagenomic Sequencing Market was valued at USD 421.49 Million in 2018 and is projected to reach USD 675.83 Million by 2026, growing at a CAGR of 6.05% from 2019 to 2026.
Global Metagenomic Sequencing Market Overview
The development of Next Generation DNA Sequencing (NGS) technology has considerably shaped molecular biology research, which has led to several discoveries and new insights. Next-generation DNA sequencing technology goes beyond long-established DNA sequencing with its applications that reach across the principles of molecular biology. Thus, it can be stated that the rise in technological advancements regarding DNA sequencing will drive the market.
Global Metagenomic Sequencing Market: Segmentation
The Metagenomic Sequencing market is segmented on the basis of workflow, product & services, technology, application, and geography.
The major players in the market are Illumina, Thermo Fisher Scientific, Pacific Biosciences of California Qiagen, BGI, Perkinelmer and Oxford Nanopore Technologies.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.